February 27, 2020 / 1:32 AM / in a month

BRIEF-Ascletis Pharma Updates On Clinical Trial Of Oral Ganovo & Ritonavir Combination Therapy On Novel Coronavirus

Feb 27 (Reuters) - Ascletis Pharma Inc:

* ASCLETIS PHARMA INC - UPDATES ON CLINICAL TRIAL OF ORAL GANOVO & RITONAVIR COMBINATION THERAPY ON NOVEL CORONAVIRUS PNEUMONIA

* ASCLETIS PHARMA INC - THE CLINICAL TRIAL OBTAINED APPROVAL FROM ETHICS COMMITTEE OF NINTH HOSPITAL OF NANCHANG ON FEB 16, 2020

* ASCLETIS PHARMA- FIRST PATIENT DIAGNOSED WITH CORONAVIRUS PNEUMONIA ENROLLED FOR TREATMENT OF GANOVO & RITONAVIR COMBINATION THERAPY ON FEB 17

* ASCLETIS PHARMA-AT FEB 27, 3 PATIENTS DISCHARGED AFTER TREATMENT AS THEY ARE SATISFIED WITH DISCHARGE STANDARDS ISSUED BY NATIONAL HEALTH COMMISSION

* ASCLETIS PHARMA INC - OTHER ENROLLED PATIENTS ARE BEING TREATED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below